Eytan M. Stein, MD

Eytan M. Stein, MD, is the Chief of the Leukemia Service, Associate Attending Physician, Clinical Investigator, and Director of the Program for Drug Development

Articles by Eytan M. Stein, MD

Trending on OncLive

Eytan M. Stein, MD

Articles by Eytan M. Stein, MD

Trending on OncLive

Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma

Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma

Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma

Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma

FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL